A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: Effect of the loss of the Mohs multiple surgery reduction exemption

Journal of the American Academy of Dermatology

Volumn 61, Issue 1, 2009, Pages 96-103

  Rogers, Howard W ^a   Coldiron, Brett M ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ARTICLE; BASAL CELL CARCINOMA; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CHEMOSURGERY; COST BENEFIT ANALYSIS; CURETTAGE; FROZEN SECTION; HEALTH CARE COST; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

AMBULATORY SURGICAL PROCEDURES; AMINOQUINOLINES; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CHEEK; COST-BENEFIT ANALYSIS; CURETTAGE; FROZEN SECTIONS; HUMANS; MOHS SURGERY; RECONSTRUCTIVE SURGICAL PROCEDURES; SKIN NEOPLASMS;

EID: 66949153255     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.07.047     Document Type: Article

References (54)

1. American Cancer Society. Cancer facts and figures 2008. Available at: http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf. Accessed August 23, 2008.
2. Demers A.A., Nugent Z., Mihalcioiu C., Wiseman M.C., and Kliewer E.V. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol 53 (2005) 320-328
3. Jemal A., Devesa S.S., Hartge P., and Tucker M.A. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 93 (2001) 678-683
4. Harris R.B., Griffith K., and Moon T.E. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 45 (2001) 528-536
5. Karagas M.R., Greenberg E.R., Spencer S.K., Stukel T.A., and Mott L.A. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 81 (1999) 555-559
6. Glass A.G., and Hoover R.N. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 262 (1989) 2097-2100
7. Rogers HW, Hinckley MR, Feldman S, Fleischer AB, Weinstock M, Coldiron BM. There is a US epidemic of keratinocyte carcinoma. Arch Dermatol. Forthcoming.
8. Housman T.S., Feldman S.R., Williford P.M., Fleischer A.B., Goldman N.D., Acostamadiedo J.M., et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 48 (2003) 425-429
9. Joseph A.K., Mark T.L., and Mueller C. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare. Dermatol Surg 27 (2001) 955-959
10. Cook J., and Zitelli J.A. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 39 5 Pt 1 (1998) 698-703
11. Bialy T.L., Whalen J., Veledar E., Lafreniere D., Spiro J., Chartier T., et al. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis. Arch Dermatol 140 (2004) 736-742
12. Essers B.A., Dirksen C.D., Nieman F.H., Smeets N.W., Krekels G.A., Prins M.H., et al. Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol 142 (2006) 187-194
13. Otley C.C. Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol 142 (2006) 1235
14. Hernández-Machin B., Borrego L., Gil-García M., and Hernández B.H. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol 46 (2007) 453-459
15. Schulte K.W., Lippold A., Auras C., Bramkamp G., Breitkopf C., Elsmann H.J., et al. Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomas. J Am Acad Dermatol 53 (2005) 993-1001
16. Caccialanza M., Piccinno R., and Grammatica A. Radiotherapy of recurrent basal and squamous cell skin carcinomas: a study of 249 re-treated carcinomas in 229 patients. Eur J Dermatol 11 (2001) 25-28
17. Lear W., Mittmann N., Barnes E., Breen D., and Murray C. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study. J Cutan Med Surg 12 (2008) 82-87
18. Wasserman Medical Publishers. Physicians' fee reference 2008 (2007), Wasserman Medical Publishers, Milwaukee, WI
19. US Department of Health and Human Services. Physician fee schedule overview. Available at: http://www.cms.hhs.gov/PhysicianFeeSched/. Accessed August 25, 2008.
20. Ingenix. Outpatient billing expert (2003), Ingenix, Salt Lake City, UT
21. Batra R.S., and Kelley L.C. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 138 (2002) 1043-1051
22. American Medical Association/Specialty Society RVS Update Committee Database (2007), American Medical Association, Washington, DC
23. Miller S.J., Alam M., Andersen J., Berg D., Bichakjian C.K., Bowen G., et al. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 5 (2007) 506-529
24. American Academy of Dermatology. Impact of loss of MPRR exemption for Mohs. Available at: www.aad.org/pm/medicare/_doc/ImpactofLossofMPRRExemptionforMohs.pdf. Accessed August 23, 2008.
25. Sussman L.A., and Liggins D.F. Incompletely excised basal cell carcinoma: a management dilemma?. Aust N Z J Surg 66 (1996) 276-278
26. Dieu T., and Macleod A.M. Incomplete excision of basal cell carcinomas: a retrospective audit. Aust N Z J Surg 72 (2002) 219-221
27. Hussain M., and Earley M.J. The incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit. Ir Med J 96 (2003) 18-20
28. Farhi D., Dupin N., Palangié A., Carlotti A., and Avril M.F. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases. Dermatol Surg 33 (2007) 1207-1214
29. Nemet A.Y., Deckel Y., Martin P.A., Kourt G., Chilov M., Sharma V., et al. Management of periocular basal and squamous cell carcinoma: a series of 485 cases. Am J Ophthalmol 142 (2006) 293-297
30. Griffiths R.W., Suvarna S.K., and Stone J. Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper?. J Plast Reconstr Aesthet Surg 60 (2007) 41-47
31. Walker P., and Hill D. Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Australas J Dermatol 47 (2006) 1-12
32. Nagore E., Grau C., Molinero J., and Fortea J.M. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol 17 (2003) 167-170
33. Silverman M.K., Kopf A.W., Bart R.S., Grin C.M., and Levenstein M.S. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol 18 (1992) 471-476
34. Rowe D.E., Carroll R.J., and Day Jr. C.L. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 15 (1989) 315-328
35. Ghauri R.R., Gunter A.A., and Weber R.A. Frozen section analysis in the management of skin cancers. Ann Plast Surg 43 (1999) 156-160
36. Cataldo P.A., Stoddard P.B., and Reed W.P. Use of frozen section analysis in the treatment of basal cell carcinoma. Am J Surg 159 (1990) 561-563
37. Bentkover S.H., Grande D.M., Soto H., Kozlicak B.A., Guillaume D., and Girouard S. Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique. Arch Facial Plast Surg 4 (2002) 114-119
38. Casey A, Goldman GD. Mohs surgery-How we practice. Presented at: 2008 American College of Mohs Surgery Meeting. May 1-4, 2008; Vancouver, BC, Canada.
39. Caccialanza M., Piccinno R., Kolesnikova L., and Gnecchi L. Radiotherapy of skin carcinomas of the pinna: a study of 115 lesions in 108 patients. Int J Dermatol 44 (2005) 513-517
40. Rodriguez-Vigil T., Vázquez-López F., and Perez-Oliva N. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation. J Am Acad Dermatol 56 (2007) 91-95
41. Thissen M.R., Neumann M.H., and Schouten L.J. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 135 (1999) 1177-1183
42. Geisse J., Caro I., Lindholm J., Golitz L., Stampone P., and Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 50 (2004) 722-733
43. Gollnick H., Barona C.G., Frank R.G., Ruzicka T., Megahed M., Tebbs V., et al. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol 15 (2005) 374-381
44. Cohen P.R., Schulze K.E., and Nelson B.R. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer. Dermatol Surg 32 (2006) 542-551
45. Wagner Jr. R.F., and Cottel W.I. Multifocal recurrent basal cell carcinoma following primary tumor treatment by electrodesiccation and curettage. J Am Acad Dermatol 17 (1987) 1047-1049
46. Kuijpers D.I., Thissen M.R., Berretty P.J., Ideler F.H., Nelemans P.J., and Neumann M.H. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma. Dermatol Surg 33 (2007) 579-587
47. Warshauer E., and Warshauer B.L. Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy. J Drugs Dermatol 7 (2008) 447-451
48. Bumsted R.M., and Ceilley R.I. Auricular malignant neoplasms. Identification of high-risk lesions and selection of method of reconstruction. Arch Otolaryngol 108 (1982) 225-231
49. Caccialanza M., Piccinno R., Beretta M., and Gnecchi L. Results and side effects of dermatologic radiotherapy: a retrospective study of irradiated cutaneous epithelial neoplasms. J Am Acad Dermatol 41 (1999) 589-594
50. Rupprecht R., Lippold A., Auras C., Bramkamp G., Breitkopf C., Elsmann H.J., et al. Late side-effects with cosmetic relevance following soft X-ray therapy of cutaneous neoplasias. J Eur Acad Dermatol Venereol 21 (2007) 178-185
51. Berridge J.K., and Morgan D.A. A comparison of late cosmetic results following two different radiotherapy techniques for treating basal cell carcinoma. Clin Oncol (R Coll Radiol) 9 (1997) 400-402
52. Petit J.Y., Avril M.F., Margulis A., Chassagne D., Gerbaulet A., Duvillard P., et al. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 105 (2000) 2544-2551
53. Silva J.J., Tsang R.W., Panzarella T., Levin W., and Wells W. Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret Hospital experience, 1982-1993. Int J Radiat Oncol Biol Phys 47 (2000) 451-459
54. Coldiron B.M., Healy C., and Bene N.I. Office surgery incidents: what seven years of Florida data show us. Dermatol Surg 34 (2008) 285-292